Thirty- and 90-day survival were better among patients treated through surgical resection for their non–small cell lung cancer (NSCLC) in Medicaid-expansion states vs nonexpansion states, according...
The proportion of certain blood immune cell types, predominately T cells and neutrophils, was linked with response to immune checkpoint inhibitors (ICIs) in patients with non–small...
Machine learning–aided prediction models are capable of learning the relationship between clinical features and later development of brain metastases (BM) in patients with non-small cell lung...
Long-term data from the CHRYSALIS trial (NCT02609776) continued to demonstrate the clinical benefit of amivantamabvmjw (Rybrevant), according to study results presented at the European Lung Cancer...
Case overview An otherwise healthy 60-year-old Caucasian woman showed an unproductive cough. She was a former smoker who quit eight years ago (13 pack years). Her...
In the Phase 1/2 KRYSTAL-1 trial (NCT03785249), the single agent adagressive provided promising objective response and disease control rate (DCR), and overall survival (OS) in previously...
Recent Comments